|
1
|
Zhang J, Wang Y, Li D and Jing S: Notch
and TGF-β/Smad3 pathways are involved in the interaction between
cancer cells and cancer-associated fibroblasts in papillary thyroid
carcinoma. Tumour Biol. 35:379–385. 2014. View Article : Google Scholar
|
|
2
|
Lloyd RV, Buehler D and Khanafshar E:
Papillary thyroid carcinoma variants. Head Neck Pathol. 5:51–56.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Silver CE, Owen RP, Rodrigo JP, Rinaldo A,
Devaney KO and Ferlito A: Aggressive variants of papillary thyroid
carcinoma. Head Neck. 33:1052–1059. 2011. View Article : Google Scholar
|
|
4
|
Scheumann GF, Gimm O, Wegener G,
Hundeshagen H and Dralle H: Prognostic significance and surgical
management of locoregional lymph node metastases in papillary
thyroid cancer. World J Surg. 18:559–567; discussion 567–568. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mazzaferri EL and Kloos RT: Clinical
review 128: Current approaches to primary therapy for papillary and
follicular thyroid cancer. J Clin Endocrinol Metab. 86:1447–1463.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pellegriti G, Scollo C, Lumera G,
Regalbuto C, Vigneri R and Belfiore A: Clinical behavior and
outcome of papillary thyroid cancers smaller than 1.5 cm in
diameter: Study of 299 cases. J Clin Endocrinol Metab.
89:3713–3720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grant CS: Recurrence of papillary thyroid
cancer after optimized surgery. Gland Surg. 4:52–62.
2015.PubMed/NCBI
|
|
8
|
Lin X, Guan H, Li H, Liu L, Liu J, Wei G,
Huang Z, Liao Z and Li Y: miR-101 inhibits cell proliferation by
targeting Rac1 in papillary thyroid carcinoma. Biomed Rep.
2:122–126. 2014.PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen YT, Kitabayashi N, Zhou XK, Fahey TJ
III and Scognamiglio T: MicroRNA analysis as a potential diagnostic
tool for papillary thyroid carcinoma. Mod Pathol. 21:1139–1146.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W,
Wu Z, Chen T, Wu W, Lobie PE, et al: MicroRNA-7 inhibits
epithelial-to-mesenchymal transition and metastasis of breast
cancer cells via targeting FAK expression. PLoS One. 7:e415232012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Zheng Y, Sun G and Xiong S:
Restoration of miR-7 expression suppresses the growth of Lewis lung
cancer cells by modulating epidermal growth factor receptor
signaling. Oncol Rep. 32:2511–2516. 2014.PubMed/NCBI
|
|
15
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Demetrick DJ, Zhang H and Beach DH:
Chromosomal mapping of the human genes CKS1 to 8q21 and CKS2 to
9q22. Cytogenet Cell Genet. 73:250–254. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Urbanowicz-Kachnowicz I, Baghdassarian N,
Nakache C, Gracia D, Mekki Y, Bryon PA and French M: ckshs
expression is linked to cell proliferation in normal and malignant
human lymphoid cells. Int J Cancer. 82:98–104. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lv M, Zhang X, Li M, Chen Q, Ye M, Liang
W, Ding L, Cai H, Fu D and Lv Z: miR-26a and its target CKS2
modulate cell growth and tumorigenesis of papillary thyroid
carcinoma. PLoS One. 8:e675912013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pallante P, Visone R, Ferracin M, Ferraro
A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M,
Negrini M, et al: MicroRNA deregulation in human thyroid papillary
carcinomas. Endocr Relat Cancer. 13:497–508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ban Y, Yamamoto G, Takada M, Hayashi S,
Ban Y, Shimizu K, Akasu H, Igarashi T, Bando Y, Tachikawa T, et al:
Proteomic profiling of thyroid papillary carcinoma. J Thyroid Res.
2012:8150792012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aragon Han P, Weng CH, Khawaja HT,
Nagarajan N, Schneider EB, Umbricht CB, Witwer KW and Zeiger MA:
MicroRNA expression and association with clinicopathologic features
in papillary thyroid cancer: A systematic review. Thyroid.
25:1322–1329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chou CK, Yang KD, Chou FF, Huang CC, Lan
YW, Lee YF, Kang HY and Liu RT: Prognostic implications of miR-146b
expression and its functional role in papillary thyroid carcinoma.
J Clin Endocrinol Metab. 98:E196–E205. 2013. View Article : Google Scholar
|
|
24
|
Ma Y, Qin H and Cui Y: miR-34a targets
GAS1 to promote cell proliferation and inhibit apoptosis in
papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Biochem
Biophys Res Commun. 441:958–963. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pines J: Cell cycle: Reaching for a role
for the Cks proteins. Curr Biol. 6:1399–1402. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spruck CH, de Miguel MP, Smith AP, Ryan A,
Stein P, Schultz RM, Lincoln AJ, Donovan PJ and Reed SI:
Requirement of Cks2 for the first metaphase/anaphase transition of
mammalian meiosis. Science. 300:647–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Frontini M, Kukalev A, Leo E, Ng YM,
Cervantes M, Cheng CW, Holic R, Dormann D, Tse E, Pommier Y, et al:
The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2
activity in maintaining replicative fidelity and neurodevelopment.
Dev Cell. 23:356–370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Martinsson-Ahlzén HS, Liberal V,
Grünenfelder B, Chaves SR, Spruck CH and Reed SI: Cyclin-dependent
kinase-associated proteins Cks1 and Cks2 are essential during early
embryogenesis and for cell cycle progression in somatic cells. Mol
Cell Biol. 28:5698–5709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen R, Feng C and Xu Y: Cyclin-dependent
kinase-associated protein Cks2 is associated with bladder cancer
progression. J Int Med Res. 39:533–540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kita Y, Nishizono Y, Okumura H, Uchikado
Y, Sasaki K, Matsumoto M, Setoyama T, Tanoue K, Omoto I, Mori S, et
al: Clinical and biological impact of cyclin-dependent kinase
subunit 2 in esophageal squamous cell carcinoma. Oncol Rep.
31:1986–1992. 2014.PubMed/NCBI
|
|
31
|
Wang J, Xu L, Liu Y, Chen J, Jiang H, Yang
S and Tan H: Expression of cyclin kinase subunit 2 in human breast
cancer and its prognostic significance. Int J Clin Exp Pathol.
7:8593–8601. 2014.
|
|
32
|
Shen DY, Fang ZX, You P, Liu PG, Wang F,
Huang CL, Yao XB, Chen ZX and Zhang ZY: Clinical significance and
expression of cyclin kinase subunits 1 and 2 in hepatocellular
carcinoma. Liver Int. 30:119–125. 2010. View Article : Google Scholar
|
|
33
|
Dorée M and Hunt T: From Cdc2 to Cdk1:
When did the cell cycle kinase join its cyclin partner? J Cell Sci.
115:2461–2464. 2002.PubMed/NCBI
|
|
34
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, et
al: MicroRNA-7 inhibits the epidermal growth factor receptor and
the Akt pathway and is down-regulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao X, Dou W, He L, Liang S, Tie J, Liu
C, Li T, Lu Y, Mo P, Shi Y, et al: MicroRNA-7 functions as an
anti-metastatic microRNA in gastric cancer by targeting
insulin-like growth factor-1 receptor. Oncogene. 32:1363–1372.
2013. View Article : Google Scholar
|
|
37
|
Kalinowski FC, Brown RAM, Ganda C, Giles
KM, Epis MR, Horsham J and Leedman PJ: MicroRNA-7: A tumor
suppressor miRNA with therapeutic potential. Int J Biochem Cell
Biol. 54:312–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Glover AR, Zhao JT, Gill AJ, Weiss J,
Mugridge N, Kim E, Feeney AL, Ip JC, Reid G, Clarke S, et al:
MicroRNA-7 as a tumor suppressor and novel therapeutic for
adrenocortical carcinoma. Oncotarget. 6:36675–36688.
2015.PubMed/NCBI
|
